Cargando…
MicroRNA-936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
Autores principales: | Xu, Lishuai, Li, Weidong, Shi, Qian, Wang, Minfeng, Li, Heng, Yang, Xiaoli, Zhang, Junjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478948/ https://www.ncbi.nlm.nih.gov/pubmed/36004468 http://dx.doi.org/10.3892/or.2022.8389 |
Ejemplares similares
-
MicroRNA-936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
por: Xu, Lishuai, et al.
Publicado: (2020) -
MicroRNA-936 Targets FGF2 to Inhibit Epithelial Ovarian Cancer Aggressiveness by Deactivating the PI3K/Akt Pathway [Retraction]
Publicado: (2021) -
MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction]
Publicado: (2021) -
MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway
por: Li, Cuihong, et al.
Publicado: (2019) -
microRNA-944 Inhibits the Malignancy of Hepatocellular Carcinoma by Directly Targeting IGF-1R and Deactivating the PI3K/Akt Signaling Pathway [Retraction]
Publicado: (2021)